XML 86 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Insider Trading Arrangements
 3 Months Ended 12 Months Ended
Dec. 31, 2023
shares
Dec. 31, 2023
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Rafael Amado [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On December 15, 2023, Rafael Amado, the Company’s President and Head of Global Oncology Research and Development, adopted a new written Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K), for the sale of up to 94,500 of the Company’s ADSs, each representing ten of the Company’s ordinary shares. This Rule 10b5-1 trading arrangement is scheduled to terminate no later than December 16, 2024.
Name Rafael Amado  
Title President and Head of Global Oncology Research and Development  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 15, 2023  
Arrangement Duration 367 days  
Aggregate Available 94,500 94,500